Cargando…
Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
TREM-1 (Triggering Receptor Expressed on Myeloid cells-1) is an immunoreceptor expressed on neutrophils, monocytes/macrophages, and endothelial cells. It amplifies the inflammatory response driven by Toll-Like Receptors (TLR) engagement. The pharmacological inhibition of TREM-1 confers protection in...
Autores principales: | Gibot, Sébastien, Jolly, Lucie, Lemarié, Jérémie, Carrasco, Kevin, Derive, Marc, Boufenzer, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779727/ https://www.ncbi.nlm.nih.gov/pubmed/31632399 http://dx.doi.org/10.3389/fimmu.2019.02314 |
Ejemplares similares
-
Pharmacological inhibition of the triggering receptor expressed on myeloid cells‐1 limits reperfusion injury in a porcine model of myocardial infarction
por: Lemarié, Jérémie, et al.
Publicado: (2015) -
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
por: Boufenzer, Amir, et al.
Publicado: (2021) -
Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
por: Sigalov, Alexander B.
Publicado: (2020) -
Clinical-grade mesenchymal stem cells derived from umbilical cord improve septic shock in pigs
por: Laroye, Caroline, et al.
Publicado: (2018) -
sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021)